A deep learning algorithm (U-Net) trained to evaluate T2-weighted and diffusion MRI had similar detection of clinically significant prostate cancer to clinical Prostate Imaging Reporting and Data S... Background Men suspected of having clinically significant prostate cancer (sPC) increasingly undergo prostate MRI. The potential of deep learning to provide diagnostic support for human interpretat...
Quantitative measurement of the mean apparent diffusion coefficient (ADC) was more accurate than prospective clinical assessment in classifying a lesion as clinically significant prostate cancer rather than a benign lesion or clinically insignificant prostate cancer. No added benefit of radiomic machine learning was present compared with mean ADC values alone. PurposeTo compare biparametric contrast-free radiomic machine learning (RML), mean apparent diffusion coefficient (ADC), and radiologist assessment for characterization of prostate lesions detected during prospective MRI interpretation.Materials and MethodsThis single-institution study included 316 men (mean age ± standard deviation, 64.0 years ± 7.8) with an indication for MRI–transrectal US fusion biopsy between May 2015 and September 2016 (training cohort, 183 patients; test cohort, 133 patients). Lesions identified by prospective clinical readings were manually segmented for mean ADC and radiomics analysis. Global and zone-specific random forest RML and mean ADC models for classification of clinically significant prostate cancer (Gleason grade group ≥ 2) were developed on the training set and the fixed models tested on an independent test set. Clinical readings, mean ADC, and radiomics were compared by using the McNemar test and receiver operating characteristic (ROC) analysis.ResultsIn the test set, ...
2 February 2017 in Journal of Magnetic Resonance Imaging
In multiparametric prostate MRI, dynamic contrast-enhancement parameters did not improve clinically significant prostate cancer prediction for apparent diffusion coefficient (ADC) PI-RADS score 3 p... Background Prostate Imaging Reporting and Data System (PI-RADS) version 2.0 requires multiparametric MRI of the prostate, including diffusion-weighted imaging (DWI) and dynamic contrast-enhanced (D...